BioNTech founders warn of Covid-19 vaccine supply issues in EU

BioNTech is working flat out with partner Pfizer to boost production of their Covid-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out. The German biotech start-up has led the vaccine race but its shot has been slow to arrive in the EU due to relatively slow approval from the bloc’s health regulator and the small size of the order placed by Brussels.

The delays have caused consternation in Germany, where some regions had to temporarily close vaccination centres days after the launch of an inoculation drive on December 27th.